356 related articles for article (PubMed ID: 12853712)
1. A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy.
Jackson CM; Esnouf MP; Lindahl TL
Pathophysiol Haemost Thromb; 2003; 33(1):43-51. PubMed ID: 12853712
[TBL] [Abstract][Full Text] [Related]
2. Monitoring anticoagulant therapy with vitamin K antagonists in patients with antiphospholipid syndrome.
Isert M; Miesbach W; Schüttfort G; Weil Y; Tirneci V; Kasper A; Weber A; Lindhoff-Last E; Herrmann E; Linnemann B
Ann Hematol; 2015 Aug; 94(8):1291-9. PubMed ID: 25859986
[TBL] [Abstract][Full Text] [Related]
3. A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy.
Berkovsky A; Sergeeva EV; Suvorov AV; Uljavova IS; Kachalova ND; Klimovich LG; Samsonova NN; Kozlov AA
Clin Chem Lab Med; 2006; 44(10):1214-7. PubMed ID: 17032133
[TBL] [Abstract][Full Text] [Related]
4. Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time.
Harder S; Graff J; Klinkhardt U; von Hentig N; Walenga JM; Watanabe H; Osakabe M; Breddin HK
Thromb Haemost; 2004 Jun; 91(6):1137-45. PubMed ID: 15175800
[TBL] [Abstract][Full Text] [Related]
5. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
Gouin I; Horellou MH; Conard J; Samama M
Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
[TBL] [Abstract][Full Text] [Related]
6. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of STA-NeoPTimal, an extraction thromboplastin reagent with ISI close to 1.
Carta M; Bonente F; Teresa Comberlato M; Pellizzari T; Marotto E; Marzari E; Giavarina D
Int J Lab Hematol; 2021 Apr; 43(2):311-317. PubMed ID: 33070473
[TBL] [Abstract][Full Text] [Related]
8. Laboratory Monitoring of Oral Vitamin K Anticoagulation.
Moffat KA; Lewis CW
Semin Thromb Hemost; 2017 Apr; 43(3):245-252. PubMed ID: 27677177
[TBL] [Abstract][Full Text] [Related]
9. An International Sensitivity Index (ISI) derived from patients with abnormal liver function improves agreement between INRs determined with different reagents.
Sermon AM; Smith JM; Maclean R; Kitchen S
Thromb Haemost; 2010 Apr; 103(4):757-65. PubMed ID: 20174759
[TBL] [Abstract][Full Text] [Related]
10. International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain.
van den Besselaar AMHP; Chantarangkul V; Angeloni F; Binder NB; Byrne M; Dauer R; Gudmundsdottir BR; Jespersen J; Kitchen S; Legnani C; Lindahl TL; Manning RA; Martinuzzo M; Panes O; Pengo V; Riddell A; Subramanian S; Szederjesi A; Tantanate C; Herbel P; Tripodi A
J Thromb Haemost; 2018 Jan; 16(1):142-149. PubMed ID: 29065247
[TBL] [Abstract][Full Text] [Related]
11. Warfarin monitoring by an anticoagulant therapy factor (ATF).
Carroll WE; Jackson RD; Carroll TA
Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):159-70. PubMed ID: 9821212
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of treatment with vitamin K antagonists: recombinant thromboplastins are more sensitive to factor VII than tissue-extract thromboplastins.
Biedermann JS; van den Besselaar AM; de Maat MP; Leebeek FW; Kruip MJ
J Thromb Haemost; 2017 Mar; 15(3):500-506. PubMed ID: 28055147
[TBL] [Abstract][Full Text] [Related]
13. [Laboratory control of oral anticoagulation].
Lourenço DM; Alves Ede C
Rev Assoc Med Bras (1992); 1995; 41(2):103-8. PubMed ID: 8520590
[TBL] [Abstract][Full Text] [Related]
14. Intrahospital correlation of the international normalized ratio.
Lazo-Langner A; Villa-Márquez R; Hernández-Hernández D; Rojas-Maya S; Piedras J
Clin Appl Thromb Hemost; 2009; 15(2):220-4. PubMed ID: 18385150
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
Crowther MA
Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
[TBL] [Abstract][Full Text] [Related]
16. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
17. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
18. Anticoagulant therapy monitoring with international normalized ratio at US academic health centers.
Yim JM; Albers GW; Vlasses PH
Ann Pharmacother; 1996 Dec; 30(12):1390-5. PubMed ID: 8968449
[TBL] [Abstract][Full Text] [Related]
19. [Control of the treatment with oral anticoagulants and prothrombin time].
Marzouka E
Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
[TBL] [Abstract][Full Text] [Related]
20. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.
Kitchen S; Preston FE
Semin Thromb Hemost; 1999; 25(1):17-25. PubMed ID: 10327216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
